Sign In
Buy EL
$83.64
+1.51 (+1.84%)
At Close: Jul 20, 2026
The Estée Lauder Companies and Forest Essentials to Enter a New Chapter in Their Long-Term Partnership
12:45am, Thursday, 05'th Mar 2026
NEW YORK & NEW DELHI--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) announced today that it has entered into an agreement, subject to regulatory approvals, to acquire the remaining inte
Why Pick P&G Over Estée Lauder Stock?
11:00am, Monday, 02'nd Mar 2026
PG is Estée Lauder's competitor in the Personal Care Products sector that offers:
Estee Lauder's Skin Care Sales Rise 6%: Are More Gains Ahead?
01:50pm, Friday, 27'th Feb 2026
EL's Skin Care sales rise 6% in Q2, fueled by China strength, innovation and tighter inventory.
Aster Capital Management DIFC Ltd Invests $649,000 in The Estee Lauder Companies Inc. $EL
03:29am, Friday, 27'th Feb 2026
Aster Capital Management DIFC Ltd purchased a new position in The Estee Lauder Companies Inc. (NYSE: EL) in the undefined quarter, according to its most recent filing with the Securities and Exchange
The Estee Lauder Companies Inc. (NYSE:EL) Receives Average Rating of “Hold” from Analysts
04:06am, Monday, 23'rd Feb 2026
The Estee Lauder Companies Inc. (NYSE: EL - Get Free Report) has been given a consensus recommendation of "Hold" by the twenty-four ratings firms that are currently covering the stock, MarketBeat.com
Beauty & Cosmetics Growth Story: Radiant Stocks You Should Watch
11:45am, Friday, 20'th Feb 2026
As the beauty and cosmetics industry balances resilience with innovation, IPAR, EL and ELF stand out for their brand strength and strategic execution.
Balmain Beauty Introduces Destin de Balmain: A New Prestige Fragrance
02:30am, Friday, 20'th Feb 2026
PARIS--(BUSINESS WIRE)--Balmain Beauty unveils Destin de Balmain, its debut prestige fragrance. The new feminine fragrance is a bold, floral fruity eau de parfum that captures the unstoppable energy o
Estée Lauder: The Storm Is Finally Over, But There Are Risks Involved
04:26pm, Wednesday, 18'th Feb 2026
After a stellar performance in 2025, Estée Lauder's stock does not appear to be overvalued. A choppy business recovery is to be expected, but this should not dissuade long-term investors. The stock's
Mark Hillman's Strategic Move: Significant Addition to State Street SPDR S&P 500 ETF Trust
12:01pm, Tuesday, 17'th Feb 2026
Insight into Mark Hillman (Trades, Portfolio)'s Fourth Quarter 2025 Investment Moves Mark Hillman (Trades, Portfolio) recently submitted the 13F filing for the
Estee Lauder Posts a Higher Gross Margin Despite Tariff Pressures
10:40am, Tuesday, 17'th Feb 2026
EL expands the second-quarter fiscal 2026 gross margin by 40 basis points to 76.5% as PRGP savings and tighter inventory help offset tariff pressure.
Beirne Wealth Consulting Services LLC Acquires New Holdings in The Estee Lauder Companies Inc. $EL
05:05am, Tuesday, 17'th Feb 2026
Beirne Wealth Consulting Services LLC bought a new position in The Estee Lauder Companies Inc. (NYSE: EL) in the third quarter, according to the company in its most recent disclosure with the SEC. The
The Estee Lauder Companies Inc. $EL Shares Sold by Advisors Asset Management Inc.
03:23am, Monday, 16'th Feb 2026
Advisors Asset Management Inc. lowered its position in shares of The Estee Lauder Companies Inc. (NYSE: EL) by 21.4% in the undefined quarter, according to its most recent disclosure with the SEC. The
Halper Sadeh LLC Encourages the Estee Lauder Companies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
11:42am, Thursday, 12'th Feb 2026
Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Candriam S.C.A. Buys 24,469 Shares of The Estee Lauder Companies Inc. $EL
05:28am, Thursday, 12'th Feb 2026
Candriam S.C.A. lifted its stake in shares of The Estee Lauder Companies Inc. (NYSE: EL) by 168.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange C
Wall Street Breakfast Podcast: Amazon Adds BETA To Cart
06:24am, Wednesday, 11'th Feb 2026
Amazon (AMZN) acquires a 5.3% stake in BETA Technologies, sharply boosting BETA's premarket share price. Moderna (MRNA) faces an FDA refusal-to-file for its mRNA-1010 influenza vaccine, citing inadequ
